Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Evaluating CD8+ T Cell Responses In Vitro.

Lemonnier FA.

Methods Mol Biol. 2019;1988:199-215. doi: 10.1007/978-1-4939-9450-2_15.

PMID:
31147942
2.

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.

Gross DA, Leborgne C, Chappert P, Masurier C, Leboeuf M, Monteilhet V, Boutin S, Lemonnier FA, Davoust J, Kichler A.

Sci Rep. 2019 Mar 8;9(1):3937. doi: 10.1038/s41598-019-40594-7.

3.

Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.

Lorente E, Barriga A, García-Arriaza J, Lemonnier FA, Esteban M, López D.

PLoS Negl Trop Dis. 2017 Oct 30;11(10):e0006036. doi: 10.1371/journal.pntd.0006036. eCollection 2017 Oct.

4.

The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Johnstone C, Lorente E, Barriga A, Barnea E, Infantes S, Lemonnier FA, David CS, Admon A, López D.

Mol Cell Proteomics. 2015 Apr;14(4):893-904. doi: 10.1074/mcp.M114.045401. Epub 2015 Jan 29.

5.

Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Rasmussen M, Harndahl M, Stryhn A, Boucherma R, Nielsen LL, Lemonnier FA, Nielsen M, Buus S.

J Immunol. 2014 Nov 15;193(10):4790-802. doi: 10.4049/jimmunol.1401689. Epub 2014 Oct 13.

6.

Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Samandary S, Kridane-Miledi H, Sandoval JS, Choudhury Z, Langa-Vives F, Spencer D, Chentoufi AA, Lemonnier FA, BenMohamed L.

Hum Immunol. 2014 Aug;75(8):715-29. doi: 10.1016/j.humimm.2014.04.016. Epub 2014 May 4.

7.

HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Boucherma R, Kridane-Miledi H, Bouziat R, Rasmussen M, Gatard T, Langa-Vives F, Lemercier B, Lim A, Bérard M, Benmohamed L, Buus S, Rooke R, Lemonnier FA.

J Immunol. 2013 Jul 15;191(2):583-93. doi: 10.4049/jimmunol.1300483. Epub 2013 Jun 17.

8.

Cloning CD8⁺ cytolytic T lymphocytes.

Lemonnier FA.

Methods Mol Biol. 2013;960:279-296. doi: 10.1007/978-1-62703-218-6_21.

PMID:
23329494
9.

Evaluating CD8⁺ T cell responses in vitro.

Lemonnier FA.

Methods Mol Biol. 2013;960:261-277. doi: 10.1007/978-1-62703-218-6_20.

PMID:
23329493
10.

HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.

Scotto M, Afonso G, Østerbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemonnier FA, Buus S, Carel JC, Boitard C, Mallone R.

Diabetes. 2012 Oct;61(10):2546-55.

11.

Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis.

Boucherma R, Kridane-Miledi H, Vives FL, Vauchy C, Borg C, Kleinclauss F, Fiette L, Tiberghien P, Lemonnier FA, Rohrlich PS, Huetz F.

Eur J Immunol. 2012 Apr;42(4):851-62. doi: 10.1002/eji.201141664.

12.

Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.

Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier FA, Carel JC, Dubois-Laforgue D, Baz B, Levy D, Gautier JF, Launay O, Bruno G, Boitard C, Sechi LA, Hutton JC, Davidson HW, Mallone R.

Diabetologia. 2012 Jul;55(7):2026-31. doi: 10.1007/s00125-012-2543-z. Epub 2012 Apr 20.

13.

Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Lorente E, García R, Mir C, Barriga A, Lemonnier FA, Ramos M, López D.

J Biol Chem. 2012 Mar 23;287(13):9990-10000. doi: 10.1074/jbc.M111.314856. Epub 2012 Feb 1.

14.

Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Lorente E, Infantes S, Barnea E, Beer I, García R, Lasala F, Jiménez M, Vilches C, Lemonnier FA, Admon A, López D.

J Virol. 2012 Jan;86(1):527-41. doi: 10.1128/JVI.05737-11. Epub 2011 Oct 26.

15.

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.

Cardinaud S, Consiglieri G, Bouziat R, Urrutia A, Graff-Dubois S, Fourati S, Malet I, Guergnon J, Guihot A, Katlama C, Autran B, van Endert P, Lemonnier FA, Appay V, Schwartz O, Kloetzel PM, Moris A.

PLoS Pathog. 2011 May;7(5):e1002049. doi: 10.1371/journal.ppat.1002049. Epub 2011 May 12.

16.

Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.

Cardinaud S, Bouziat R, Rohrlich PS, Tourdot S, Weiss L, Langlade-Demoyen P, Burgevin A, Fiorentino S, van Endert P, Lemonnier FA.

AIDS. 2009 Sep 24;23(15):1945-54. doi: 10.1097/QAD.0b013e32832fae88.

PMID:
19644347
17.

Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II.

Maeda A, Okazaki T, Inoue M, Kitazono T, Yamasaki M, Lemonnier FA, Ozaki S.

Int Immunopharmacol. 2009 Sep;9(10):1183-8. doi: 10.1016/j.intimp.2009.06.006. Epub 2009 Jun 21.

PMID:
19540938
18.

Measurement of CD8 T cell responses in human type 1 diabetes.

Martinuzzi E, Lemonnier FA, Boitard C, Mallone R.

Ann N Y Acad Sci. 2008 Dec;1150:61-7. doi: 10.1196/annals.1447.015. Review.

PMID:
19120269
19.

Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells.

Chevaliez S, Balanant J, Maillard P, Lone YC, Lemonnier FA, Delpeyroux F.

Virology. 2008 Nov 25;381(2):203-14. doi: 10.1016/j.virol.2008.08.006. Epub 2008 Sep 27.

20.

An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Tagaram HR, Watson AM, Lemonnier FA, Staveley-O'Carroll K, Tevethia SS, Schell TD.

Virology. 2008 Jun 20;376(1):183-90. doi: 10.1016/j.virol.2008.02.033. Epub 2008 Apr 10.

21.

The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.

Pajot A, Schnuriger A, Moris A, Rodallec A, Ojcius DM, Autran B, Lemonnier FA, Lone YC.

Eur J Immunol. 2007 Sep;37(9):2635-44.

22.

A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge.

Scardino A, Alimandi M, Correale P, Smith SG, Bei R, Firat H, Cusi MG, Faure O, Graf-Dubois S, Cencioni G, Marrocco J, Chouaib S, Lemonnier FA, Jackson AM, Kosmatopoulos K.

Cancer Res. 2007 Jul 15;67(14):7028-36.

23.

HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.

Mathieu MG, Knights AJ, Pawelec G, Riley CL, Wernet D, Lemonnier FA, Straten PT, Mueller L, Rees RC, McArdle SE.

Cancer Immunol Immunother. 2007 Dec;56(12):1885-95. Epub 2007 May 9.

PMID:
17487488
24.

Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide.

Faure O, Graff-Dubois S, Alves PM, Cornet S, Duffour MT, Scardino A, Gross DA, Miconnet I, Salcedo M, Chouaib S, Lemonnier FA, Abastado JP, Kosmatopoulos K.

Oncol Rep. 2007 Mar;17(3):679-85.

PMID:
17273751
25.

Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects.

Pajot A, Michel ML, Mancini-Bourgine M, Ungeheuer MN, Ojcius DM, Deng Q, Lemonnier FA, Lone YC.

Microbes Infect. 2006 Oct;8(12-13):2783-90. Epub 2006 Sep 12.

PMID:
17045504
26.

Expression of iron transport proteins divalent metal transporter-1, Ferroportin-1, HFE and transferrin receptor-1 in human monocyte-derived dendritic cells.

Brinkmann M, Teuffel R, Laham N, Ehrlich R, Decker P, Lemonnier FA, Pascolo S.

Cell Biochem Funct. 2007 May-Jun;25(3):287-96.

PMID:
16927405
27.

STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.

Alves PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, Gross DA, Miconnet I, Chouaib S, Fizazi K, Soria JC, Lemonnier FA, Kosmatopoulos K.

Cancer Immunol Immunother. 2006 Dec;55(12):1515-23. Epub 2006 Apr 19.

PMID:
16622681
28.

Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.

Fazilleau N, Delarasse C, Sweenie CH, Anderton SM, Fillatreau S, Lemonnier FA, Pham-Dinh D, Kanellopoulos JM.

Eur J Immunol. 2006 Mar;36(3):533-43.

29.

[HFE, a MHC class Ib molecule that regulates iron metabolism].

Rohrlich PS, Kanellopoulos J, Lemonnier FA.

Med Sci (Paris). 2006 Jan;22(1):24-6. French. No abstract available.

30.

Direct recognition by alphabeta cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function.

Rohrlich PS, Fazilleau N, Ginhoux F, Firat H, Michel F, Cochet M, Laham N, Roth MP, Pascolo S, Nato F, Coppin H, Charneau P, Danos O, Acuto O, Ehrlich R, Kanellopoulos J, Lemonnier FA.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12855-60. Epub 2005 Aug 25.

31.

Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE.

Miyahara Y, Naota H, Wang L, Hiasa A, Goto M, Watanabe M, Kitano S, Okumura S, Takemitsu T, Yuta A, Majima Y, Lemonnier FA, Boon T, Shiku H.

Clin Cancer Res. 2005 Aug 1;11(15):5581-9.

32.

Identification of naturally processed HLA-A2--restricted proinsulin epitopes by reverse immunology.

Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM.

Diabetes. 2005 Jul;54(7):2053-9.

33.

A single amino acid substitution improves the in vivo immunogenicity of the HPV16 oncoprotein E7(11-20) cytotoxic T lymphocyte epitope.

Schreurs MW, Kueter EW, Scholten KB, Lemonnier FA, Meijer CJ, Hooijberg E.

Vaccine. 2005 Jul 1;23(31):4005-10. Epub 2005 Apr 11.

PMID:
15963358
34.

Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopes.

Schirmbeck R, Riedl P, Fissolo N, Lemonnier FA, Bertoletti A, Reimann J.

J Immunol. 2005 Apr 15;174(8):4647-56.

35.

The non-classical HLA class I molecule HFE does not influence the NK-like activity contained in fresh human PBMCs and does not interact with NK cells.

Pascolo S, Ginhoux F, Laham N, Walter S, Schoor O, Probst J, Rohrlich P, Obermayr F, Fisch P, Danos O, Ehrlich R, Lemonnier FA, Rammensee HG.

Int Immunol. 2005 Feb;17(2):117-22. Epub 2004 Dec 27.

PMID:
15623549
36.

Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.

Tine JA, Firat H, Payne A, Russo G, Davis SW, Tartaglia J, Lemonnier FA, Demoyen PL, Moingeon P.

Vaccine. 2005 Jan 11;23(8):1085-91.

PMID:
15620483
37.

A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice.

Pajot A, Michel ML, Fazilleau N, Pancré V, Auriault C, Ojcius DM, Lemonnier FA, Lone YC.

Eur J Immunol. 2004 Nov;34(11):3060-9.

38.
39.

HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system.

Ginhoux F, Turbant S, Gross DA, Poupiot J, Marais T, Lone Y, Lemonnier FA, Firat H, Perez N, Danos O, Davoust J.

Mol Ther. 2004 Aug;10(2):279-89.

40.

Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules.

Pajot A, Pancré V, Fazilleau N, Michel ML, Angyalosi G, Ojcius DM, Auriault C, Lemonnier FA, Lone YC.

Int Immunol. 2004 Sep;16(9):1275-82. Epub 2004 Jul 12.

PMID:
15249541
41.

MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides.

Bar-Haim E, Paz A, Machlenkin A, Hazzan D, Tirosh B, Carmon L, Brenner B, Vadai E, Mor O, Stein A, Lemonnier FA, Tzehoval E, Eisenbach L.

Br J Cancer. 2004 Jul 19;91(2):398-407.

42.

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.

Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.

Hum Immunol. 2004 May;65(5):514-22.

PMID:
15172452
43.

Infection-induced expansion of a MHC Class Ib-dependent intestinal intraepithelial gammadelta T cell subset.

Davies A, Lopez-Briones S, Ong H, O'Neil-Marshall C, Lemonnier FA, Nagaraju K, Metcalf ES, Soloski MJ.

J Immunol. 2004 Jun 1;172(11):6828-37.

44.

IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules.

Terme M, Tomasello E, Maruyama K, Crépineau F, Chaput N, Flament C, Marolleau JP, Angevin E, Wagner EF, Salomon B, Lemonnier FA, Wakasugi H, Colonna M, Vivier E, Zitvogel L.

J Immunol. 2004 May 15;172(10):5957-66.

45.

NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors.

Maraskovsky E, Sjölander S, Drane DP, Schnurr M, Le TT, Mateo L, Luft T, Masterman KA, Tai TY, Chen Q, Green S, Sjölander A, Pearse MJ, Lemonnier FA, Chen W, Cebon J, Suhrbier A.

Clin Cancer Res. 2004 Apr 15;10(8):2879-90.

46.

Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames.

Cardinaud S, Moris A, Février M, Rohrlich PS, Weiss L, Langlade-Demoyen P, Lemonnier FA, Schwartz O, Habel A.

J Exp Med. 2004 Apr 19;199(8):1053-63. Epub 2004 Apr 12.

47.

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

Gross DA, Graff-Dubois S, Opolon P, Cornet S, Alves P, Bennaceur-Griscelli A, Faure O, Guillaume P, Firat H, Chouaib S, Lemonnier FA, Davoust J, Miconnet I, Vonderheide RH, Kosmatopoulos K.

J Clin Invest. 2004 Feb;113(3):425-33.

48.

Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.

Faure O, Graff-Dubois S, Bretaudeau L, Derré L, Gross DA, Alves PM, Cornet S, Duffour MT, Chouaib S, Miconnet I, Grégoire M, Jotereau F, Lemonnier FA, Abastado JP, Kosmatopoulos K.

Int J Cancer. 2004 Mar 1;108(6):863-70.

49.

EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.

Alves PM, Faure O, Graff-Dubois S, Gross DA, Cornet S, Chouaib S, Miconnet I, Lemonnier FA, Kosmatopoulos K.

Cancer Res. 2003 Dec 1;63(23):8476-80.

50.

Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.

Dadaglio G, Morel S, Bauche C, Moukrim Z, Lemonnier FA, Van Den Eynde BJ, Ladant D, Leclerc C.

Int Immunol. 2003 Dec;15(12):1423-30.

PMID:
14645151

Supplemental Content

Loading ...
Support Center